abstract
- Safety, Tolerability and PK of Omadacycline in Pediatric Subjects with Suspected or Confirmed Bacterial Infections
PEDPK: PTK0796-PEDPK-20110- A Phase 1, Open-Label, Multi-Center Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intravenous and Oral Doses of Omadacycline in Pediatric Subjects with Suspected or Confirmed Bacterial Infections
Grant
Overview
date/time interval
- January 2023 - December 2025
awarded by
Affiliation
contributor
- Salma Syed Principal Investigator